α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis
- 作者C. Y. Wu; Y. Feng; G. C. Qian; J. H. Wu; J. Luo; Y. Wang; G. J. Chen; X. K. Guo; Z. J. Wang
- 卷第162卷
- 期第1期
- 印刷ISSN0009-9104
- 电子ISSN1365-2249
- 文件大小1155.07KB
- 发表时间2010
- DOI10.1111/j.1365-2249.2010.04233.x
- 页码178-187
Inhibitory oligodeoxynucleotides − therapeutic promise for systemic autoimmune diseases?P. Lenert · 2005
Lactating Adenoma: A Diagnosis of ExclusionTreneth P. Baker; Jeffrey T. Lenert; John Parker; Bonnie Kemp; Anne Kushwaha; Gregory Evans; Kelly K. Hunt · 2001
Mastectomy and Contralateral Prophylactic Mastectomy Rates: An Institutional ReviewSameer Damle; Christine B. Teal; Joanne J. Lenert; Elizabeth C. Marshall; Qing Pan; Anita P. McSwain · 2011
Mastectomy and Contralateral Prophylactic Mastectomy Rates: An Institutional ReviewSameer Damle; Christine B. Teal; Joanne J. Lenert; Elizabeth C. Marshall; Qing Pan; Anita P. McSwain · 2011
What Should Be Reported in a Methods Section on Utility Assessment?Stalmeier, P. F. M.; Goldstein, M. K.; Holmes, A. M.; Lenert, L.; Miyamoto, J.; Stiggelbout, A. M.; Torrance, G. W.; Tsevat, J. · Medical Decision Making · 2001
Activation of Marginal Zone B Cells from Lupus Mice with Type A(D) CpG-OligodeoxynucleotidesBrummel, R.; Lenert, P. · The Journal of Immunology · 2005
A Public Health Grid (PHGrid): Architecture and value proposition for 21st century public healthT. Savel; K. Hall; B. Lee; V. McMullin; M. Miles; J. Stinn; P. White; D. Washington; T. Boyd; L. Lenert · 2010
Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 bindingAshman, R. F.; Goeken, J. A.; Latz, E.; Lenert, P. · International Immunology · 2011